关于PDE5i药物对延长高频听力影响的后续研究
Chandrahas Chandanshive1,2, R Rangasayee3
1Ph.D Scholar, Allied Health Sciences, Maharashtra University of Health Sciences, Ali Yavar Jung National Institute of Speech and Hearing Disability (Divyangjan), Bandra (West), Mumbai, Maharashtra, India.
概括
固酶5型抑制剂 (PDE5i) 可能会对听力产生负面影响. 即使在服用药物之前,PDE5i用户的听觉敏感性也较差,这表明需要进一步调查的潜在耳毒性.
科学领域:
- 耳部毒理学 耳部毒理学
- 药理学 药理学是指药理学的学科.
- 听力学 听力学是指听力学.
背景情况:
- 固酶5型抑制剂 (PDE5i) 广泛用于勃起功能障碍,肺高血压和良性前列腺增生症.
- 关于PDE5i的耳毒性存在有限的研究,尽管与尾功能至关重要的氧化通路的潜在联系.
研究的目的:
- 研究PDE5抑制剂对听觉敏感性的潜在耳毒性影响.
- 为了评估PDE5抑制剂使用者的听力值,与健康的对照组相比.
主要方法:
- 使用扩展高频听力测量 (EHFA) 来评估60名参与者的听力敏感性 (30名PDE5i用户,30名对照).
- 进行药物治疗前后的听力测量,以检测听力值的变化.
主要成果:
- 与对照组相比,PDE5i使用者在药物治疗前和药物治疗后的听力值明显较差.
- 在PDE5i用户中,药物治疗前的听力障碍表明了潜在的先前存在的敏感性或与勃起功能障碍等潜在疾病的关联.
结论:
- 研究结果表明PDE5抑制剂可能具有耳毒性潜力,因此需要进一步研究长期影响.
- 建议在使用PDE5抑制剂的人群中密切监测听力敏感性.
相关概念视频
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
124
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
124
01:31Hearing
51.7K
When we hear a sound, our nervous system is detecting sound waves—pressure waves of mechanical energy traveling through a medium. The frequency of the wave is perceived as pitch, while the amplitude is perceived as loudness.
51.7K